Literature DB >> 932904

Diagnosis of lipogranulomatosis (Farber disease) by use of cultured fibroblasts.

J T Dulaney, A Milunsky, J B Sidbury, N Hobolth, H W Moser.   

Abstract

The enzyme defect in Farber disease, a deficiency of acid ceramidase, has been demonstrated in cultured skin fibroblasts, which provides a means of confirming the diagnosis during life. The assay can also be performed using cultured amniotic fluid cells and is a potential tool for detection of carriers of the disease.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 932904     DOI: 10.1016/s0022-3476(76)80927-4

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  15 in total

Review 1.  Basic findings and current developments in sphingolipidoses.

Authors:  H Pilz; R Heipertz; D Seidel
Journal:  Hum Genet       Date:  1979-03-12       Impact factor: 4.132

Review 2.  Farber disease: an ultrastructural study. Report of a case and review of the literature.

Authors:  L Zappatini-Tommasi; C Dumontel; P Guibaud; C Girod
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

3.  Accumulation of ordered ceramide-cholesterol domains in farber disease fibroblasts.

Authors:  Natalia Santos Ferreira; Michal Goldschmidt-Arzi; Helena Sabanay; Judith Storch; Thierry Levade; Maria Gil Ribeiro; Lia Addadi; Anthony H Futerman
Journal:  JIMD Rep       Date:  2013-07-12

4.  A specific ultrastructural marker for disseminated lipogranulomatosis (Faber).

Authors:  C Schmoeckel; M Hohlfed
Journal:  Arch Dermatol Res       Date:  1979-10       Impact factor: 3.017

Review 5.  Drug targeting of sphingolipid metabolism: sphingomyelinases and ceramidases.

Authors:  Daniel Canals; David M Perry; Russell W Jenkins; Yusuf A Hannun
Journal:  Br J Pharmacol       Date:  2011-06       Impact factor: 8.739

6.  Identification of ASAH1 as a susceptibility gene for familial keloids.

Authors:  Regie Lyn P Santos-Cortez; Ying Hu; Fanyue Sun; Fairouz Benahmed-Miniuk; Jian Tao; Jitendra K Kanaujiya; Samuel Ademola; Solomon Fadiora; Victoria Odesina; Deborah A Nickerson; Michael J Bamshad; Peter B Olaitan; Odunayo M Oluwatosin; Suzanne M Leal; Ernst J Reichenberger
Journal:  Eur J Hum Genet       Date:  2017-07-26       Impact factor: 4.246

7.  Substrate-specificities of acid and alkaline ceramidases in fibroblasts from patients with Farber disease and controls.

Authors:  T Momoi; Y Ben-Yoseph; H L Nadler
Journal:  Biochem J       Date:  1982-08-01       Impact factor: 3.857

8.  First-trimester enzyme exclusion of Farber disease using a micromethod with [3H]ceramide.

Authors:  V S Akhunov; S S Gargaun; X D Krasnopolskaya
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

9.  A case of combined Farber and Sandhoff disease.

Authors:  C Fusch; R Huenges; H W Moser; A C Sewell; W Roggendorf; B Kustermann-Kuhn; A Poulos; W F Carey; K Harzer
Journal:  Eur J Pediatr       Date:  1989-04       Impact factor: 3.183

10.  Diagnosis of metachromatic leukodystrophy, Krabbe disease, and Farber disease after uptake of fatty acid-labeled cerebroside sulfate into cultured skin fibroblasts.

Authors:  T Kudoh; D A Wenger
Journal:  J Clin Invest       Date:  1982-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.